Skip to Content

Raplixa

Licence status
Withdrawn: 27/03/2018
Active substances
Human fibrinogen, Human thrombin
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/14/985/001-003
Licence holder
Mallinckrodt Pharmaceuticals Ireland Limited

Licence information

ATC code
B02BC Local hemostatics, B02BC30 combinations
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/03/2015